World's Best Scientists 2026 revealed!
Award Badge
Best Scientists
2025
Award Badge
Medicine
USA
2026

D-Index & Metrics

Best Scientists

D-Index
206
Citations
176145
World Ranking
234
National Ranking
156

Medicine

D-Index
213
Citations
185468
World Ranking
118
National Ranking
80

William J. Sandborn publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where William J. Sandborn sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,969 publications — 100th percentile

100% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

William J. Sandborn D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where William J. Sandborn sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 213 D-Index — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Medicine in United States Leader Award
  • 2025 - Research.com Best Scientists Award
  • 2025 - Research.com Medicine in United States Leader Award
  • 2023 - Research.com Medicine in United States Leader Award

Overview

William J. Sandborn is affiliated with the University of California, San Diego in the United States. The primary fields of study in their research include Medicine and Biochemistry, Genetics and Molecular Biology, with specific focus on Genetics, Epidemiology, Surgery, Immunology, and Oncology as subfields.

Their research topics predominantly cover Inflammatory Bowel Disease, Microscopic Colitis, and Eosinophilic Esophagitis, as well as studies related to Helicobacter pylori gastroenterology, Immunodeficiency and Autoimmune Disorders, Autoimmune and Inflammatory Disorders, and Biosimilars and Bioanalytical Methods.

Frequent publication venues for their work include Gastroenterology, Journal of Crohn's and Colitis, Clinical Gastroenterology and Hepatology, The American Journal of Gastroenterology, and Inflammatory Bowel Diseases.

Notable recent papers authored or co-authored by William J. Sandborn are:

  • STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD, 2021, Gastroenterology
  • Global chemical effects of the microbiome include new bile-acid conjugations, 2020, Nature
  • Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials, 2022, The Lancet
  • Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis, 2021, New England Journal of Medicine
  • Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial, 2021, The Lancet

Frequent co-authors working with William J. Sandborn include:

  • Silvio Danese
  • Brian G. Feagan
  • Geert D'Haens
  • Bruce E. Sands
  • Laurent Peyrin-Biroulet

William J. Sandborn's publication record reflects research that intersects clinical gastroenterology and molecular biology, with a focus on therapeutic developments for inflammatory bowel conditions and related autoimmune disorders.

Best Publications

  • Infliximab for induction and maintenance therapy for ulcerative colitis.

    Paul Rutgeerts;William J Sandborn;Brian G Feagan;Walter Reinisch

  • Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

    Jean Frédéric Colombel;William J. Sandborn;Walter Reinisch;Gerassimos J. Mantzaris

  • Vedolizumab as induction and maintenance therapy for ulcerative colitis.

    Brian G Feagan;Paul Rutgeerts;Bruce E Sands;Stephen Hanauer

  • Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial.

    Jean–Frédéric Colombel;William J. Sandborn;Paul Rutgeerts;Robert Enns

  • Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

    William J. Sandborn;Brian G. Feagan;Paul Rutgeerts;Stephen Hanauer

  • Crohn's disease

    Daniel C Baumgart;William J Sandborn

  • Inflammatory bowel disease: clinical aspects and established and evolving therapies.

    Daniel C Baumgart;William J Sandborn

  • Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I Trial

    Stephen B. Hanauer;William J. Sandborn;Paul Rutgeerts;Richard N. Fedorak

  • Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

    L. Peyrin-Biroulet;W. Sandborn;B. E. Sands;W. Reinisch;W. Reinisch

  • STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

    Dan Turner;Amanda Ricciuto;Ayanna Lewis;Ferdinando D’Amico

  • A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis.

    Geert D’Haens;William J. Sandborn;Brian G. Feagan;Karel Geboes

  • Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

    William J. Sandborn;Chinyu Su;Bruce E. Sands;Geert R. D’Haens

  • Certolizumab pegol for the treatment of Crohn’s disease:

    William J. Sandborn;Brian G. Feagan;Simeon Stoinov;Pieter J. Honiball

  • The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study

    William A. Faubion;Edward V. Loftus;William S. Harmsen;Alan R. Zinsmeister

  • A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998.

    Christoph Gasche;Jurgen Scholmerich;Jorn Brynskov;Geert D'Haens

  • Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis

    William J. Sandborn;Gert van Assche;Walter Reinisch;Jean–Frederic Colombel

  • Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial.

    William J. Sandborn;Stephen B. Hanauer;Seymour Katz;Michael Safdi

  • Maintenance Therapy with Certolizumab Pegol for Crohn's Disease

    Stefan Schreiber;Mani Khaliq-Kareemi;Ian C. Lawrance;Ole Østergaard Thomsen

  • Adalimumab for Maintenance Treatment of Crohn's Disease: Results of the CLASSIC II Trial

    William J Sandborn;Stephen B Hanauer;Paul J Rutgeerts;Richard N Fedorak

  • Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial.

    William J. Sandborn;Paul Rutgeerts;Robert Enns;Stephen B. Hanauer

Frequent Co-Authors

Brian G. Feagan
Brian G. Feagan University of Western Ontario
Jean-Frederic Colombel
Jean-Frederic Colombel Icahn School of Medicine at Mount Sinai
Edward V. Loftus
Edward V. Loftus Mayo Clinic
Stephen B. Hanauer
Stephen B. Hanauer Northwestern University
Bruce E. Sands
Bruce E. Sands Icahn School of Medicine at Mount Sinai
Geert R. D'Haens
Geert R. D'Haens University of Amsterdam
Siddharth Singh
Siddharth Singh University of California, San Diego
Walter Reinisch
Walter Reinisch Medical University of Vienna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medicine but seeking alternative or flexible pathways, there is a growing range of online degrees related to healthcare and the medical field. Choosing an online program can make higher education more affordable and accessible, especially for working adults or career changers.

Registered nurses looking to advance quickly may consider some of the cheapest online BSN to DNP programs, allowing them to obtain a Doctor of Nursing Practice degree with lower costs and greater flexibility. Pharmacists, meanwhile, might explore earning their 3 year online PharmD, streamlining their path to a doctoral degree without relocating or pausing their careers.

Not all healthcare roles require a doctorate or direct patient care. For instance, those drawn to the business and technology side of healthcare can look into online schools for health information management, a field critical for data integrity and patient record safety. Similarly, students seeking quick entry into healthcare jobs may examine how much does it cost to become a medical coder—a vital, in-demand profession supporting hospitals and clinics from behind the scenes.

Best Scientists Citing William J. Sandborn

Trending Scientists

Recently Published Articles